Using artificial intelligence to predict outcomes of organic chemistry at IBM Research – Zurich
Could a small molecule complement regenerative therapies in spinal cord injury?
On the virtues of automated quantitative structure–activity relationship: the new kid on the block
A novel synthesis technique could open the door for the development of new medicinal compounds
How can we replace, refine and reduce the use of animals in research? An interview with Anthony Holmes
Spheroids and high-throughput screening: a method for identifying anticancer therapeutics
Multifunctional drugs for Parkinson’s disease: an interview with Aloke Dutta
Research article: enhancing anticancer activity through the combination of bioreducing agents and triterpenes